Presentations
GTB-3550 ASH 2020 Meeting Supplement Presentation – Treatment of HR-MDS Patient
GTB-3550 Clinical Trial Interim Results: Erica Warlick, M.D., Principal Investigator. American Society of Hematology (ASH) meeting, December 5, 2020.
GT Biopharma Interview with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco
- « Previous ?>
- 1
- 2
- 3